在基因编辑方面，公司推出了包括CAS9、CAS12a等CAS系列蛋白，主要用于定点基因编辑等，以提供高编辑效率。 (记者 蔡鼎) 免责声明：本文内容与数据 ...

At this time, the core can perform genome editing with S.p. Cas9 or A.s. Cas12a/Cpf1. The targeting will be done in embryos using microinjection to introduce the CRISPR reagents. The investigator will ...

To access the live webcasts of Eitas Medicine’s presentations, please visit the “Investors” section of the Company’s website at www.editasmedicine.com. An archived replay will be available for ...